Here, we provide a picture of the recent advances in mammalian cell line development and discuss the criteria a biotech company should consider when starting its cell line development process.
Published on 2018-02-08 Therapeutic antibodies development
We have discussed antibody humanisation with Olivier Léger. He is an expert in antibody engineering with over 25 years' experience in the field.
What methods to use for glycan characterisation of your antibody and protein products during process development?
In this second article of our series on QC development for biotherapeutics, our partner PROTEODYNAMICS, an expert company in glycan analysis and protein characterisation, gives a review of the relevant methods to characterise the glycosylation of your biotherapeutic candidates.